Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine. [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating ABT-614 for safety, tolerability, and kidney function in adults with type 2 diabetes mellitus and chronic kidney disease wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• ABT-614

Snippet

Sponsor: Abbott | Conditions: Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine | Phase 1 | Status: COMPLETED